Total Payments
$10,529
2024 Payments
$885.77
Companies
39
Transactions
314
Medicare Patients
29,568
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$6,130 (58.2%)
Other$4,125 (39.2%)
Education$274.44 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,130 | 301 | 58.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,125 | 3 | 39.2% |
| Education | $274.44 | 10 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vifor Pharma, Inc. | $3,192 | 16 | $0 (2023) |
| Relypsa, Inc. | $1,615 | 32 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $822.68 | 38 | $0 (2024) |
| Amgen Inc. | $581.25 | 23 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $516.24 | 24 | $0 (2019) |
| OPKO Pharmaceuticals, LLC | $357.83 | 30 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $353.92 | 12 | $0 (2019) |
| Aurinia Pharma U.S., Inc. | $337.54 | 16 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $280.13 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $267.33 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $885.77 | 49 | Amgen Inc. ($206.93) |
| 2023 | $1,043 | 37 | AstraZeneca Pharmaceuticals LP ($254.75) |
| 2022 | $1,011 | 46 | AstraZeneca Pharmaceuticals LP ($179.45) |
| 2021 | $3,622 | 37 | Vifor Pharma, Inc. ($3,113) |
| 2020 | $1,314 | 9 | Relypsa, Inc. ($1,249) |
| 2019 | $868.85 | 39 | Otsuka America Pharmaceutical, Inc. ($176.63) |
| 2018 | $836.39 | 50 | Mallinckrodt LLC ($172.07) |
| 2017 | $948.63 | 47 | Mallinckrodt LLC ($245.32) |
All Payment Transactions
314 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Nephrology | ||||||
| 12/17/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: NEPHROLOGY | ||||||
| 12/17/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $1.35 | General |
| Category: NEPHROLOGY | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $23.84 | General |
| 11/07/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Immunology | ||||||
| 11/06/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: NEPHROLOGY | ||||||
| 11/06/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $1.66 | General |
| Category: NEPHROLOGY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $8.12 | General |
| Category: Nephrology | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Cardio-renal | ||||||
| 10/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: NEPHROLOGY | ||||||
| 09/11/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: Nephrology | ||||||
| 09/11/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $2.13 | General |
| Category: NEPHROLOGY | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/09/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Inflammation | ||||||
| 08/29/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $18.79 | General |
| 08/28/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 08/28/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 08/22/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $123.95 | General |
| Category: Inflammation | ||||||
| 08/06/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 08/01/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: NEPHROLOGY | ||||||
| 07/31/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $1.26 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 8,006 | 13,095 | $2.8M | $368,211 |
| 2022 | 42 | 7,815 | 13,384 | $1.3M | $340,528 |
| 2021 | 41 | 6,998 | 11,316 | $1.0M | $287,147 |
| 2020 | 41 | 6,749 | 16,622 | $1.2M | $309,629 |
Total Patients
29,568
Total Services
54,417
Medicare Billing
$1.3M
Procedure Codes
167
All Medicare Procedures & Services
167 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 627 | 754 | $529,353 | $66,641 | 12.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 186 | 892 | $306,723 | $40,084 | 13.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 172 | 435 | $287,648 | $37,692 | 13.1% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 22 | 131 | $256,708 | $34,613 | 13.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 192 | 916 | $242,923 | $31,940 | 13.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 164 | 787 | $205,974 | $26,999 | 13.1% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 472 | 584 | $144,645 | $23,442 | 16.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 362 | 406 | $72,106 | $11,701 | 16.2% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 25 | 1,180 | $135,630 | $7,110 | 5.2% |
| 82610 | Cystatin c (enzyme inhibitor) level | Office | 2023 | 351 | 388 | $43,115 | $6,994 | 16.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 65 | 130 | $51,722 | $6,872 | 13.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 50 | 51 | $49,162 | $6,562 | 13.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 608 | 758 | $35,338 | $5,725 | 16.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 572 | 674 | $12,132 | $5,626 | 46.4% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 76 | 188 | $40,856 | $5,599 | 13.7% |
| 80069 | Kidney function blood test panel | Office | 2023 | 497 | 637 | $33,175 | $5,390 | 16.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 295 | 295 | $29,594 | $4,997 | 16.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $38,370 | $4,973 | 13.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 613 | 759 | $23,669 | $4,256 | 18.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 20 | 25 | $29,558 | $4,051 | 13.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 601 | 742 | $23,061 | $3,738 | 16.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 37 | 37 | $26,678 | $3,455 | 13.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 53 | $23,290 | $3,157 | 13.6% |
| 84550 | Uric acid level, blood | Office | 2023 | 469 | 592 | $16,055 | $2,595 | 16.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 197 | 206 | $13,052 | $2,105 | 16.1% |
About Dr. Rohit Gupta, M.D
Dr. Rohit Gupta, M.D is a Nephrology healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1386641496.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rohit Gupta, M.D has received a total of $10,529 in payments from pharmaceutical and medical device companies, with $885.77 received in 2024. These payments were reported across 314 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($6,130).
As a Medicare-enrolled provider, Gupta has provided services to 29,568 Medicare beneficiaries, totaling 54,417 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 167 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Chattanooga, TN
- Active Since 07/05/2005
- Last Updated 05/28/2010
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1386641496
Products in Payments
- Veltassa (Drug) $4,807
- ACTHAR (Biological) $749.25
- FARXIGA (Drug) $493.73
- LUPKYNIS (Drug) $337.54
- JARDIANCE (Drug) $300.92
- Parsabiv (Biological) $298.68
- LOKELMA (Drug) $252.71
- RAYALDEE (Drug) $223.11
- Kerendia (Drug) $218.72
- TAVNEOS (Drug) $206.93
- TARPEYO (Drug) $201.90
- JYNARQUE (Drug) $193.22
- SAMSCA (Drug) $160.70
- MICRA (Device) $152.24
- Auryxia (Drug) $147.55
- Pristine (Device) $135.29
- Rayaldee (Drug) $134.72
- BENLYSTA (Biological) $118.95
- Rituxan (Biological) $112.17
- KRYSTEXXA (Biological) $100.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Chattanooga
Hans Yehnert, Md, MD
Nephrology — Payments: $5,326
Nephrology $5,326
Nilesh Patel, M.d, M.D
Nephrology — Payments: $3,184
Nephrology $3,184
John Mccarley, M.d, M.D
Nephrology — Payments: $2,939
Nephrology $2,939
Brant Holt, Md, MD
Nephrology — Payments: $2,929
Nephrology $2,929
Mandeep Grewal, Md, MD
Nephrology — Payments: $2,449
Nephrology $2,449
Claude Galphin, Md, MD
Nephrology — Payments: $2,379
Nephrology $2,379